DOLIPRANELIQUIZ 1000 mg, suspension buvable en sachet édulcorée au sorbitol, au sucralose et à la néohespéridine DC — 8 sachetspolytéréphtalate (PET) aluminium polyéthylène de 12 ml
Medicine package · Base de données publique des médicaments (BDPM), ANSM, HAS et Assurance Maladie · France
-
CIP13
3400930229613 -
CIP7
3022961 -
CIS
69530780
What the source publishes
- Holder
- OPELLA HEALTHCARE FRANCE
- Active ingredients
- PARACÉTAMOL
- Form
- suspension buvable
- Package
- 8 sachetspolytéréphtalate (PET) aluminium polyéthylène de 12 ml
- Routes
- orale
- Administrative status
- authorised
- Marketing status
- Déclaration de commercialisation
- Authorised on
- 2021-07-01
Names this record is found by
- DOLIPRANELIQUIZ 1000 mg, suspension buvable en sachet édulcorée au sorbitol, au sucralose et à la néohespéridine DC — 8 sachetspolytéréphtalate (PET) aluminium polyéthylène de 12 ml
- DOLIPRANELIQUIZ 1000 mg, suspension buvable en sachet édulcorée au sorbitol, au sucralose et à la néohespéridine DC
- PARACÉTAMOL
Complete source data
{
"cis": "69530780",
"cip7": "3022961",
"form": "suspension buvable",
"name": "DOLIPRANELIQUIZ 1000 mg, suspension buvable en sachet édulcorée au sorbitol, au sucralose et à la néohespéridine DC — 8 sachetspolytéréphtalate (PET) aluminium polyéthylène de 12 ml",
"cip13": "3400930229613",
"holder": "OPELLA HEALTHCARE FRANCE",
"routes": [
"orale"
],
"holders": [
"OPELLA HEALTHCARE FRANCE"
],
"currency": "EUR",
"marketed": true,
"bdmStatus": null,
"useDomain": "unknown",
"publicPrice": null,
"authorisedOn": "2021-07-01",
"compositions": [
{
"name": "PARACÉTAMOL",
"nature": "SA",
"strength": "1000,00 mg",
"linkageNumber": "1",
"substanceCode": "02202",
"dosageReference": "un sachet",
"pharmaceuticalElement": "suspension"
}
],
"sourceStatus": "Présentation active",
"supplyRegime": null,
"dispensingFee": null,
"medicinePrice": null,
"regionalRules": "not-collected",
"targetSpecies": [],
"specialityName": "DOLIPRANELIQUIZ 1000 mg, suspension buvable en sachet édulcorée au sorbitol, au sucralose et à la néohespéridine DC",
"marketingStatus": "Déclaration de commercialisation",
"publicationDates": {
"CIS_bdpm": "2026-01-08",
"CIS_CIP_bdpm": "2026-11-19",
"CIS_CPD_bdpm": "2026-01-08",
"CIS_COMPO_bdpm": "2026-01-08"
},
"specialityListed": true,
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "fr.ansm.bdpm"
},
"collectiveApproval": "oui",
"packageDescription": "8 sachetspolytéréphtalate (PET) aluminium polyéthylène de 12 ml",
"patientEligibility": "not-assessed",
"reimbursementRates": [],
"marketingDeclaredOn": "2022-04-01",
"targetSpeciesStatus": "not-reported",
"additionalMonitoring": false,
"administrativeStatus": "authorised",
"prescriptionCategory": "unknown",
"activeIngredientNames": [
"PARACÉTAMOL"
],
"authorisationProcedure": "Procédure nationale",
"prescriptionConditions": [],
"reimbursementIndications": null,
"authorisationSourceStatus": "Autorisation active",
"europeanAuthorisationNumber": null,
"presentationAdministrativeStatus": "authorised"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=fr" \
--data-urlencode "sourceId=fr.ansm.bdpm" \
--data-urlencode "id=fr:ansm:packages:3400930229613"